These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9085184)

  • 1. Strategy for designing specific antisense oligonucleotide sequences.
    Mitsuhashi M
    J Gastroenterol; 1997 Apr; 32(2):282-7. PubMed ID: 9085184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Software to determine optimal oligonucleotide sequences based on hybridization simulation data.
    Hyndman D; Cooper A; Pruzinsky S; Coad D; Mitsuhashi M
    Biotechniques; 1996 Jun; 20(6):1090-4, 1096-7. PubMed ID: 8780880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural rearrangements in RNA on the binding of an antisense oligonucleotide: implications for the study of intra-molecular RNA interactions and the design of cooperatively acting antisense reagents with enhanced efficacy.
    Sohail M; Doran G; Kang S; Akhtar S; Southern EM
    J Drug Target; 2005 Jan; 13(1):61-70. PubMed ID: 15848955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical report: Part 1. Basic requirements for designing optimal oligonucleotide probe sequences.
    Mitsuhashi M
    J Clin Lab Anal; 1996; 10(5):277-84. PubMed ID: 8887007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences.
    Yoshida T; Naito Y; Sasaki K; Uchida E; Sato Y; Naito M; Kawanishi T; Obika S; Inoue T
    Genes Cells; 2018 Jun; 23(6):448-455. PubMed ID: 29667281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
    Anazodo MI; Duta E; Friesen AD; Wright JA
    Biochem Biophys Res Commun; 1996 Dec; 229(1):305-9. PubMed ID: 8954123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of regions in multiple sequence alignments thermodynamically suitable for targeting by consensus oligonucleotides: application to HIV genome.
    Matveeva OV; Foley BT; Nemtsov VA; Gesteland RF; Matsufuji S; Atkins JF; Ogurtsov AY; Shabalina SA
    BMC Bioinformatics; 2004 Apr; 5():44. PubMed ID: 15115544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.
    Lloyd BH; Giles RV; Spiller DG; Grzybowski J; Tidd DM; Sibson DR
    Nucleic Acids Res; 2001 Sep; 29(17):3664-73. PubMed ID: 11522838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide technology: from EST to therapeutics.
    Giles RV
    Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias in nucleotide composition of antisense oligonucleotides.
    Smetsers TF; Boezeman JB; Mensink EJ
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):63-7. PubMed ID: 8783797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides made of 2'-O-alkylRNA: their properties and applications in RNA biochemistry.
    Lamond AI; Sproat BS
    FEBS Lett; 1993 Jun; 325(1-2):123-7. PubMed ID: 7685712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico determination of potential antisense targets for human beta-globin variants.
    Arrigo P; Ivaldi G; Cardo PP
    In Silico Biol; 2002; 2(2):143-50. PubMed ID: 12066838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
    Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
    Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?
    Morishita R; Aoki M; Kaneda Y
    Curr Drug Targets; 2000 Jul; 1(1):15-23. PubMed ID: 11475534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide.
    Olie RA; Hall J; Natt F; Stahel RA; Zangemeister-Wittke U
    Biochim Biophys Acta; 2002 Jun; 1576(1-2):101-9. PubMed ID: 12031489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide strategies in physiology.
    Baertschi AJ
    Mol Cell Endocrinol; 1994 May; 101(1-2):R15-24. PubMed ID: 9397970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
    Bruice TW; Lima WF
    Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide treatment of ras-induced tumors in nude mice.
    Wickstrom E
    Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.